PHARMACEUTICAL COMPOSITION COMPRISING ENAVOGLIFLOZIN FOR PREVENTING OR TREATING CARDIOVASCULAR AGING DISEASES
US20260097060A1 · Application publication visible
immortal.lifeExplore source-linked longevity patent families and topic connections associated with the applicant name DAEWOONG PHARMACEUTICAL CO., LTD..
This independent page groups EPO bibliographic records in which this name appears as an applicant or assignee. It is not a corporate profile, ownership opinion, portfolio valuation or ranking.
US20260097060A1 · Application publication visible